🇺🇸 FDA
Patent

US 7972793

Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

granted A61KA61K31/00A61K31/496

Quick answer

US patent 7972793 (Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype) held by SureGene LLC expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SureGene LLC
Grant date
Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/00, A61K31/496, A61K31/519, A61K31/5415